In this large-scale prospective study, high pre-diagnosis concentrations of OPG were associated with an increased risk of death after an ER+ breast cancer diagnosis, especially among women with BMI less than 25 kg/m2. This evidence concerns the gene TNFRSF11B and breast carcinoma.